UNSPSC 85662227: Replacement of left upper leg tendon with autologous tissue substitute, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to replacement of left upper leg tendon with autologous tissue substitute, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0LRM07Z

UNSPSC 85662227 Replacement of left upper leg tendon with autologous tissue substitute, open approach is a Commodity code that shows little relevant recent activity. The code's nominal scope describes a specific surgical procedure, but the recent state and local opportunities posted under this code—independent medical evaluations, pharmacy benefit management, occupational medical surveillance, emergency youth detention healthcare, and temporary health professional staffing—do not align with orthopedic tendon replacement work. The mismatch suggests either taxonomy misclassification at the source or that state and local procurement offices are using this code as a catch-all for health services administration and staffing rather than for discrete surgical procedures.

The opportunities that do appear span diverse issuing bodies and geographies with no identifiable pattern of repeat buyers: the City of Phoenix Retirement Office (Arizona) seeking independent medical evaluation services for disability determinations; the City of Long Beach (California) requesting surgical carve-out benefits management; the Washington State Department of Transportation (Washington) soliciting occupational medical surveillance; Harris County Juvenile Probation Department (Texas) issuing an RFI for emergency and specialty healthcare for detained youth; Collier County (Florida) procuring pharmacy benefit management; and Santa Clara County Health System (California) establishing a temporary health professional staffing pool. Recent solicitations span RFPs, RFQs, and RFIs with response dates scattered from September through October 2026. Given the divergence between the code's stated clinical scope and actual procurement activity, this code warrants verification before resource allocation toward state and local opportunities.